7-146254550-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.97+137577T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.22 in 152,174 control chromosomes in the GnomAD database, including 9,007 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 9007 hom., cov: 33)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.83

Publications

7 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.636 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.97+137577T>C
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.97+137577T>C
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000625365.2
TSL:5
c.97+137577T>C
intron
N/AENSP00000485955.1
CNTNAP2
ENST00000637150.1
TSL:5
n.26+137577T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.219
AC:
33375
AN:
152056
Hom.:
8981
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.642
Gnomad AMI
AF:
0.0493
Gnomad AMR
AF:
0.111
Gnomad ASJ
AF:
0.0724
Gnomad EAS
AF:
0.0534
Gnomad SAS
AF:
0.121
Gnomad FIN
AF:
0.0207
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.0479
Gnomad OTH
AF:
0.198
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.220
AC:
33448
AN:
152174
Hom.:
9007
Cov.:
33
AF XY:
0.214
AC XY:
15938
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.643
AC:
26652
AN:
41472
American (AMR)
AF:
0.110
AC:
1683
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0724
AC:
251
AN:
3468
East Asian (EAS)
AF:
0.0533
AC:
276
AN:
5180
South Asian (SAS)
AF:
0.121
AC:
581
AN:
4818
European-Finnish (FIN)
AF:
0.0207
AC:
220
AN:
10614
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.0479
AC:
3261
AN:
68018
Other (OTH)
AF:
0.197
AC:
417
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
809
1618
2427
3236
4045
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
268
536
804
1072
1340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0925
Hom.:
2661
Bravo
AF:
0.246
Asia WGS
AF:
0.118
AC:
413
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.077
DANN
Benign
0.46
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs802524; hg19: chr7-145951642; API